CIK 0000897448
- Accelerated filer
AMARIN CORP PLCUK
Sign in to watch- Ticker
- AMRN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- Operating
- Phone
- +353 16699020
- Business address
- SPACES SOUTH DOCKLANDS, BLOCK C, 77 SIR JOHN ROGERSON'S QUAY, DUBLIN 2, Ireland
- Former names
- AMARIN CORP PLC\UK, AMARIN PHARMACEUTICALS PLC, ETHICAL HOLDINGS PLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-09-24 | Ketchum Steven B Chief Scientific Officer | Sale | −49,450 | $10.94 | $541K | 441,297 |
| 2018-09-24 | Ketchum Steven B Chief Scientific Officer | Sale | −100,000 | $12.00 | $1.2M | 341,297 |
| 2018-09-24 | Ketchum Steven B Chief Scientific Officer | Option exercise · Stock Option (Right to Buy) | −20,834 | 44,270 | ||
| 2018-09-24 | Ketchum Steven B Chief Scientific Officer | Option exercise · Stock Option (Right to Buy) | −158,334 | 41,666 | ||
| 2018-09-24 | Ketchum Steven B Chief Scientific Officer | Option exercise · Stock Option (Right to Buy) | −112,500 | 67,500 | ||
| 2018-09-24 | Ketchum Steven B Chief Scientific Officer | Option exercise · Stock Option (Right to Buy) | −142,500 | 37,500 | ||
| 2018-09-24 | Ketchum Steven B Chief Scientific Officer | Option exercise · Stock Option (Right to Buy) | −52,147 | 80,853 | ||
| 2018-09-24 | Ketchum Steven B Chief Scientific Officer | Option exercise · Stock Option (Right to Buy) | −33,750 | 0 | ||
| 2018-09-24 | Ketchum Steven B Chief Scientific Officer | Option exercise · Stock Option (Right to Buy) | −100,000 | 500,000 | ||
| 2018-09-24 | Kennedy Joseph T General Counsel | Option exercise | +202,500 | $2.04 | $413K | 420,434 |
| 2018-09-24 | Kennedy Joseph T General Counsel | Option exercise | +83,985 | $1.02 | $86K | 504,419 |
| 2018-09-24 | Kennedy Joseph T General Counsel | Option exercise | +712,491 | $2.50 | $1.8M | 1,216,910 |
| 2018-09-24 | Kennedy Joseph T General Counsel | Option exercise | +80,730 | $1.40 | $113K | 1,297,640 |
| 2018-09-24 | Kennedy Joseph T General Counsel | Sale | −884,800 | $10.27 | $9.1M | 412,840 |
| 2018-09-24 | Kennedy Joseph T General Counsel | Sale | −55,200 | $11.14 | $615K | 357,640 |
| 2018-09-24 | Kennedy Joseph T General Counsel | Sale | −139,706 | $12.14 | $1.7M | 217,934 |
| 2018-09-24 | Kennedy Joseph T General Counsel | Option exercise · Stock Option (Right to Buy) | −202,500 | 0 | ||
| 2018-09-24 | Kennedy Joseph T General Counsel | Option exercise · Stock Option (Right to Buy) | −83,985 | 9,765 | ||
| 2018-09-24 | Kennedy Joseph T General Counsel | Option exercise · Stock Option (Right to Buy) | −712,491 | 187,509 | ||
| 2018-09-24 | Kennedy Joseph T General Counsel | Option exercise · Stock Option (Right to Buy) | −80,730 | 44,270 |
Page 83 of 95 · 1,885 trades